Summary
Naturally occurs in marine sponges (Smenospongia aurea, Verongula rigida) and in the skin of the Caribbean reef toad. In rodent studies it produced antidepressant-like and anxiolytic behaviors at non-stimulant doses and acted as a 5-HT1A partial agonist while showing little psychedelic activity, which may explain its unusually sedating, dreamy character compared with DMT. Very sparse human data; user reports describe warm body load, closed-eye visuals, and pronounced relaxation rather than intense hallucinations. Because brominated tryptamines are virtually unresearched in humans, start with allergy tests (less than 2 mg inhaled) and use a sitter.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Vaporized | 10-25mg | 25-35mg | 35-65mg | 65mg+ |
| Vapourized | 10-25mg | 25-35mg | 35-65mg | 65mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Vaporized | 1-1 min | 1-4 min | 3-19 min | 60 min | 1 min | 15.0-90.0 hrs |
| Oral | 1.0-2.0 hrs | - | - | - | - | 15.0-90.0 hrs |
| Vapourized | 1-1 min | - | 15-90 min | - | - | 15.0-90.0 hrs |
Tolerance
Build-up
develops rapidly after a single use
Reset
7–14 days for baseline
Effects
Positive
- Physical Euphoria
- Muscle relaxation
- Physical euphoria
- Anxiolytic
Negative
- Respiratory depression
- Motor impairment
- Sedation
- Dilated pupils
- Sedative
- Dystaxia
Positive
- Relaxation
- Emotion Enhancement
- Introspection
- Anxiety suppression
Negative
- Thought Deceleration
- Motor control loss
- Amnesia
- Thought deceleration
- Dizziness
- Time Distortion
Positive
- Colour Enhancement
- Pattern Recognition Enhancement
- Bodily Control Enhancement
- Color enhancement
- Increased libido
Negative
- Visual Acuity Suppression
- Disinhibition
- Visual acuity suppression
- Visual distortions
- Dulled perception